Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value
Advanced Medical Journal · 04.09.2026 · 11 (3) · 287-296
DOI: 10.56056/amj.2026.512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Medical Journal, online erschienen am 04.09.2026. Verfasst von Krestiyan Manuail und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background and Objectives: Prostate cancer progression is influenced by Gleason scores and prostate-specific antigen levels. This study aims to find the association between these markers and the duration until disease progression in patients undergoing androgen deprivation therapy.
Methods
This retrospective cohort study included 108 patients with prostate cancer treated at Nanakali Hospital and Rizgary Teaching Hospital in Erbil, Iraq. Data on demographics, clinical variables (prostate-specific antigen levels, the lowest prostate-specific antigen level reached after initiation of androgen deprivation therapy, Gleason score, and time to disease progression), and sites of metastasis were collected.
Results
Patients with metastatic disease had higher initial prostate-specific antigen levels (median 102 nanograms per deciliter) compared to non-metastatic patients (median 20.5 nanograms per deciliter, p
Zitieren
APA
Manuail, K., Muhialdin, J., & Salih, F. (2026). Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value. Advanced Medical Journal, 11(3), 287-296. https://doi.org/10.56056/amj.2026.512
Vancouver
Manuail K, Muhialdin J, Salih F. Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value. Advanced Medical Journal. 2026;11(3):287-296. doi:10.56056/amj.2026.512
BibTeX
@article{Manuail2026,
author = {Manuail, Krestiyan and Muhialdin, Jang and Salih, Fahmi},
title = {Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value},
journal = {Advanced Medical Journal},
year = {2026},
volume = {11},
number = {3},
pages = {287--296},
doi = {10.56056/amj.2026.512}
}
EUVIMED